{"id":"W2022175692","doi":"10.1016/j.coviro.2015.03.016","title":"Pexa-Vec double agent engineered vaccinia: oncolytic and active immunotherapeutic","year":2015,"lang":"en","type":"review","venue":"Current Opinion in Virology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":44,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Oncolytic virus; Vaccinia; Immunotherapy; Biology; Cancer immunotherapy; Immune system; Cancer research; Virotherapy; Immunology; Virus; Cancer; Gene; Recombinant DNA","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006906782,0.0008736534,0.002666024,0.0008089555,0.0001463341,0.00003187117,0.0006203119,0.001320018,0.0004516943],"category_scores_gemma":[0.00005366518,0.000749741,0.000397081,0.0004102219,0.0003307799,0.0001379749,0.0002835104,0.001792581,0.0007811209],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003840915,"about_ca_system_score_gemma":0.0006556162,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003357536,"about_ca_topic_score_gemma":0.000002757335,"domain_scores_codex":[0.9957433,0.001293896,0.001202477,0.0008391372,0.0000735241,0.0008476687],"domain_scores_gemma":[0.9980538,0.0005373709,0.000541461,0.0007408089,0.00007581871,0.00005067509],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001454443,0.0003790739,0.000004994779,0.003553824,0.0006380609,0.000002547057,0.0007110811,9.627767e-7,0.0001685995,0.0003770646,0.001486327,0.991223],"study_design_scores_gemma":[0.004540426,0.0005347228,0.0001137703,0.002799365,0.0002673409,0.0003105428,0.00005874799,0.00000150788,0.00002870066,0.00005640867,0.9906288,0.0006596683],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003547196,0.985063,0.00001738834,0.0000702848,0.01272761,0.001478037,0.00008532155,0.00009181134,0.0001118478],"genre_scores_gemma":[0.0003048055,0.9975439,0.000006120063,0.00002487554,0.0001688357,0.000518641,0.0007145208,0.0001025014,0.00061578],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9905633,"threshold_uncertainty_score":0.9999969,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1138948042108642,"score_gpt":0.3891487742216211,"score_spread":0.2752539700107569,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}